SCHEMBL3108422

SCHEMBL3108422

CCNC(=O)c1ccc(C)c(-n2cnc3ccc(OCCN(C)CCC#N)cc3c2=O)c1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 19/20 0.59
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3111793 0.91 MAPK14 (0.61) MAPK14TP53
SCHEMBL3114559 0.91 MAPK14 (0.61) MAPK14TP53
SCHEMBL3113468 0.91 MAPK14 (0.63) MAPK14TP53
SCHEMBL3109174 0.91 MAPK14 (0.48) MAPK14
SCHEMBL3106203 0.89 MAPK14 (0.61) MAPK14TP53
SCHEMBL3105908 0.88 MAPK14 (0.59) MAPK14TP53
SCHEMBL3110088 0.87 MAPK14 (0.61) MAPK14TP53
SCHEMBL3120717 0.86 MAPK14 (0.58) MAPK14TP53
SCHEMBL3105861 0.86 MAPK14 (0.58) MAPK14TP53
SCHEMBL3105870 0.84 MAPK14 (0.63) MAPK14TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100256120-A1 AMIDE DERIVATIVES ASTRAZENECA AB 2010-10-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256120-A1 AMIDE DERIVATIVES IL1B, IL1A, IL6 MAPK14 2363/4885TP53 1524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.